Diethylhomospermine
Diethylhomospermine had been in phase II clinical trials by SunPharm (merged into GelTex in 1999, then acquired by Genzyme in 2000, now a subsidiary of Sanofi) for the treatment of AIDS-related chronic diarrhea. However, this research has been discontinued.
General Information
Update Date：2016-04-22
- Drug Name：
- Diethylhomospermine
- Research Code：
- BE-4-4-4; DE-444; DEHOP; DEHSPM
- Trade Name：
- MOA：
- Unknown
- Indication：
- AIDS-related chronic diarrhea
- Status：
- Phase Ⅱ (Discontinued)
- Company：
- Genzyme (Originator)
- Sales：
- ATC Code：
Chemical Structure
Update Date：2016-02-04
|
Molecular Weight | 286.50 | ||||||||||||
| Formula | C16H38N4 | |||||||||||||
| CAS No. | 119422-08-1 (Diethylhomospermine); | |||||||||||||
| Chemical Name | 1,4-Butanediamine, N1,N4-bis[4-(ethylamino)butyl]- | |||||||||||||
| Diethylhomospermine （Free Acid/Base）Parameters： | ||||||||||||||
|
||||||||||||||
| *：Calculated by ACD/Labs software V11.02. | ||||||||||||||